Over the past two decades, World Cancer Day, which falls on Feb. 4, has become an important day for patients and for clinicians alike. This year, the Union for International Cancer Control, which organized the initiative, will launch a new three-year campaign aimed at bringing together individuals, organizations and governments to create awareness and help close the gap in cancer care. “By 2030, it is estimated that 75% of all premature deaths due to cancer will occur in low- and middle-income countries,” said Anil d’Cruz, the union’s president.
When Prof. James Brenton was seeing one of his patients at Addenbrooke’s Hospital recently for ovarian cancer treatment, he needed to review all her studies and treatments. The information was complex and lengthy: blood test results, genomic tests, imaging studies and reports from past therapy. Brenton hadn’t been able to attend the tumor board meeting the day before, where his colleagues — radiation oncologists, medical oncologists, radiologists, pathologists and surgeons — had reviewed her data. The recap from the meeting was helpful, but overly brief.